# Effects of Esketamine on Postpartum Depression

> **NCT05229913** · PHASE4 · UNKNOWN · sponsor: **Qinghai University** · enrollment: 500 (estimated)

## Conditions studied

- Postpartum Depression

## Interventions

- **DRUG:** Esketamine is not added
- **DRUG:** Esketamine 0.2mg/kg
- **DRUG:** Esketamine 0.4mg/kg
- **DRUG:** Esketamine 0.6mg/kg
- **DRUG:** Esketamine 0.8mg/kg

## Key facts

- **NCT ID:** NCT05229913
- **Lead sponsor:** Qinghai University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-20
- **Primary completion:** 2022-09-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05229913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05229913, "Effects of Esketamine on Postpartum Depression". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05229913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*